Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Bottomley A, Tridello G, Coens C, Rolland F, Tesselaar ME, Leemans CR, Hupperets P, Licitra L, Vermorken JB, Van Den Weyngaert D, Truc G, Barillot I, Lefebvre JL. Bottomley A, et al. Among authors: licitra l. Cancer. 2014 Feb 1;120(3):390-8. doi: 10.1002/cncr.28392. Epub 2013 Oct 25. Cancer. 2014. PMID: 24452673 Free article. Clinical Trial.
Cancer of the oropharynx.
Licitra L, Bernier J, Grandi C, Merlano M, Bruzzi P, Lefebvre JL. Licitra L, et al. Crit Rev Oncol Hematol. 2002 Jan;41(1):107-22. doi: 10.1016/s1040-8428(01)00129-9. Crit Rev Oncol Hematol. 2002. PMID: 11796235 Review.
Cancer of the larynx.
Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, Lefebvre JL. Licitra L, et al. Crit Rev Oncol Hematol. 2003 Jul;47(1):65-80. doi: 10.1016/s1040-8428(03)00017-9. Crit Rev Oncol Hematol. 2003. PMID: 12853099 Review.
Head and neck cancer.
Psyrri A, Burtness B, Harari PM, Vermorken JB, Licitra L, Sasaki CT. Psyrri A, et al. Among authors: licitra l. J Oncol. 2009;2009:358098. doi: 10.1155/2009/358098. Epub 2010 Feb 4. J Oncol. 2009. PMID: 20169126 Free PMC article. No abstract available.
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study.
Urba S, van Herpen CM, Sahoo TP, Shin DM, Licitra L, Mezei K, Reuter C, Hitt R, Russo F, Chang SC, Hossain AM, Frimodt-Moller B, Koustenis A, Hong RL. Urba S, et al. Among authors: licitra l. Cancer. 2012 Oct 1;118(19):4694-705. doi: 10.1002/cncr.27449. Epub 2012 Mar 20. Cancer. 2012. PMID: 22434360 Free article. Clinical Trial.
Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies.
Licitra L, Störkel S, Kerr KM, Van Cutsem E, Pirker R, Hirsch FR, Vermorken JB, von Heydebreck A, Esser R, Celik I, Ciardiello F. Licitra L, et al. Eur J Cancer. 2013 Apr;49(6):1161-8. doi: 10.1016/j.ejca.2012.11.018. Epub 2012 Dec 19. Eur J Cancer. 2013. PMID: 23265711 Clinical Trial.
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
Vermorken JB, Stöhlmacher-Williams J, Davidenko I, Licitra L, Winquist E, Villanueva C, Foa P, Rottey S, Skladowski K, Tahara M, Pai VR, Faivre S, Blajman CR, Forastiere AA, Stein BN, Oliner KS, Pan Z, Bach BA; SPECTRUM investigators. Vermorken JB, et al. Among authors: licitra l. Lancet Oncol. 2013 Jul;14(8):697-710. doi: 10.1016/S1470-2045(13)70181-5. Epub 2013 Jun 6. Lancet Oncol. 2013. PMID: 23746666 Free article. Clinical Trial.
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.
Saloura V, Cohen EE, Licitra L, Billan S, Dinis J, Lisby S, Gauler TC. Saloura V, et al. Among authors: licitra l. Cancer Chemother Pharmacol. 2014 Jun;73(6):1227-39. doi: 10.1007/s00280-014-2459-z. Epub 2014 Apr 9. Cancer Chemother Pharmacol. 2014. PMID: 24714973 Clinical Trial.
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III.
Singer S, Araújo C, Arraras JI, Baumann I, Boehm A, Brokstad Herlofson B, Castro Silva J, Chie WC, Fisher S, Guntinas-Lichius O, Hammerlid E, Irarrázaval ME, Jensen Hjermstad M, Jensen K, Kiyota N, Licitra L, Nicolatou-Galitis O, Pinto M, Santos M, Schmalz C, Sherman AC, Tomaszewska IM, Verdonck de Leeuw I, Yarom N, Zotti P, Hofmeister D; EORTC Quality of Life and the EORTC Head and Neck Cancer Groups. Singer S, et al. Among authors: licitra l. Head Neck. 2015 Sep;37(9):1358-67. doi: 10.1002/hed.23762. Epub 2014 Jul 21. Head Neck. 2015. PMID: 24832623
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments.
Locati LD, Licitra L, Agate L, Ou SH, Boucher A, Jarzab B, Qin S, Kane MA, Wirth LJ, Chen C, Kim S, Ingrosso A, Pithavala YK, Bycott P, Cohen EE. Locati LD, et al. Among authors: licitra l. Cancer. 2014 Sep 1;120(17):2694-703. doi: 10.1002/cncr.28766. Epub 2014 May 20. Cancer. 2014. PMID: 24844950 Free article. Clinical Trial.
440 results